These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12619573)

  • 1. [Role of stress in the etiopathogenesis of duodenal ulcer in young patients].
    Lazebnik LB; Arbuzova VG; Sokolova GN; Astaf'eva OV; Petrakov AV; Nilova TV; Chikunova BZ
    Eksp Klin Gastroenterol; 2002; (5):30-3, 126-7. PubMed ID: 12619573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.
    García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J
    Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic value of gastric metaplasia in the duodenal mucosa in patients with Helicobacter pylori positive duodenal bulb ulcer].
    Marshalko OV; Konorev MR
    Klin Med (Mosk); 2008; 86(2):43-8. PubMed ID: 18368792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastroduodenal peptic ulcer: descriptive study].
    Mbengue M; Seck A; Dia D; Diouf ML; Ka MM; Boye CS; Mboup S; Moreira Diop T
    Dakar Med; 2003; 48(3):176-80. PubMed ID: 15776626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Helicobacter pylori infection on gastric acid secretion and meal-stimulated serum gastrin in children.
    Kato S; Ozawa K; Koike T; Sekine H; Ohara S; Minoura T; Iinuma K
    Helicobacter; 2004 Apr; 9(2):100-5. PubMed ID: 15068410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of Helicobacter pylori-negative duodenal ulcer disease.
    Chen TS; Chang FY
    Hepatogastroenterology; 2008; 55(86-87):1615-8. PubMed ID: 19102353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of class I and II MHC receptors in Helicobacter pylori-positive patients with active gastritis and duodenal ulcer.
    Suleymanov Z
    Turk J Gastroenterol; 2003 Sep; 14(3):168-72. PubMed ID: 14655059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age and eradication treatment of duodenal ulcer].
    Minushkin ON; Volodin DV; Zverkov IV; Ivanova OI; Shuleshova AG; Burdina EG
    Ter Arkh; 2007; 79(2):22-6. PubMed ID: 17460963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Shiratori Y
    Am J Gastroenterol; 2005 May; 100(5):1037-42. PubMed ID: 15842576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Time course changes in morphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers].
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME
    Ter Arkh; 2006; 78(2):26-31. PubMed ID: 16613092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease.
    Kato S; Nishino Y; Ozawa K; Konno M; Maisawa S; Toyoda S; Tajiri H; Ida S; Fujisawa T; Iinuma K
    J Gastroenterol; 2004 Aug; 39(8):734-8. PubMed ID: 15338366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients.
    Peetsalu M; Valle J; Härkönen M; Maaroos HI; Peetsalu A
    Hepatogastroenterology; 2005; 52(63):785-91. PubMed ID: 15966205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basal and food-stimulated blood gastrin in duodenal ulcer].
    Shvarts VIa; Kuznetsov BG; Frolkov VK; Saakian AG
    Ter Arkh; 1984; 56(8):97-100. PubMed ID: 6495220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of non-Helicobacter pylori ulcer disease].
    Grinevich VB; Uspenskiĭ IuP; Shabanova GZh; Shcherbina NN
    Ter Arkh; 2002; 74(2):24-7. PubMed ID: 11899818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interleukin-1 RN polymorphism and Helicobacter pylori infection in the development of duodenal ulcer.
    Hsu PI; Li CN; Tseng HH; Lai KH; Hsu PN; Lo GH; Lo CC; Yeh JJ; Ger LP; Hsiao M; Yamaoka Y; Hwang IR; Chen A
    Helicobacter; 2004 Dec; 9(6):605-13. PubMed ID: 15610073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The hormonal characteristics of the pathogenesis of gastric peptic ulcer and duodenal peptic ulcer].
    Loginov AS; Arbuzova VG; Amirov NSh; Astaf'eva OV; Zvenigorodskaia LA
    Ter Arkh; 1995; 67(10):19-23. PubMed ID: 8779096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic humoral anti-Helicobacter pylori immune response in patients with gastric malignancies and benign gastroduodenal disease.
    Manojlovic N; Nikolic L; Pilcevic D; Josifovski J; Babic D
    Hepatogastroenterology; 2004; 51(55):282-4. PubMed ID: 15011886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.